New animal models of Alzheimer’s disease that display insulin desensitization in the brain

References

Agrawal, R., Tyagi, E., Shukla, R., and Nath, C. (2011). Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model. Eur. Neuropsychopharmacol. 21, 261–273.10.1016/j.euroneuro.2010.11.009Search in Google Scholar

Ahren, B., Pacini, G., Foley, J.E., and Schweizer, A. (2005). Improved meal-related β-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year. Diabetes Care 28, 1936–1940.10.2337/diacare.28.8.1936Search in Google Scholar

Asakawa, A., Inui, A., Inui, T., Katsuura, G., Fujino, M.A., and Kasuga M. (2003). Leptin treatment ameliorates anxiety in ob/ob obese mice. J. Diabetes Complications 17, 105–107.10.1016/S1056-8727(02)00185-XSearch in Google Scholar

Aviles-Olmos, I., Dickson, J., Kefalopoulou, Z., Djamshidian, A., Ell, P., Soderlund, T., Whitton, P., Wyse, R., Isaacs, T., Lees, A., et al. (2013). Exenatide and the treatment of patients with Parkinson’s disease. J. Clin. Invest. 123, 2730–2736.10.1172/JCI68295Search in Google Scholar

Bales, K.R., Liu, F., Wu, S., Lin, S., Koger, D., DeLong, C., Hansen, J.C., Sullivan, P.M., and Paul, S.M. (2009). Human APOE isoform-dependent effects on brain β-amyloid levels in PDAPP transgenic mice. J. Neurosci. 29, 6771–6779.10.1523/JNEUROSCI.0887-09.2009Search in Google Scholar

Banks, A.S., Davis, S.M., Bates, S.H., and Myers M.G., Jr. (2000). Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 275, 14563–14572.10.1074/jbc.275.19.14563Search in Google Scholar

Blokland, A. and Jolles J. (1994). Behavioral and biochemical effects of an ICV injection of streptozotocin in old Lewis rats. Pharmacol. Biochem. Behav. 47, 833–837.10.1016/0091-3057(94)90284-4Search in Google Scholar

Buettner, R., Parhofer, K.G., Woenckhaus, M., Wrede, C.E., Kunz-Schughart, L.A., Scholmerich, J., and Bollheimer, L.C. (2006). Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J. Mol. Endocrinol. 36, 485–501.10.1677/jme.1.01909Search in Google Scholar PubMed

Campion, D., Dumanchin, C., Hannequin, D., Dubois, B., Belliard, S., Puel, M., Thomas-Anterion, C., Michon, A., Martin, C., Charbonnier, F., et al. (1999). Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am. J. Hum. Genet. 65, 664–670.10.1086/302553Search in Google Scholar PubMed PubMed Central

Carro, E. and Torres-Aleman, I. (2004). Insulin-like growth factor I and Alzheimer’s disease, therapeutic prospects? Expert Rev. Neurother. 4, 79–86.10.1586/14737175.4.1.79Search in Google Scholar PubMed

Chen, D. and Wang, M.W. (2005). Development and application of rodent models for type 2 diabetes. Diabetes Obes. Metab. 7, 307–317.10.1111/j.1463-1326.2004.00392.xSearch in Google Scholar PubMed

Chen, Z. and Zhong, C. (2013). Decoding Alzheimer’s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog. Neurobiol. 108, 21–43.10.1016/j.pneurobio.2013.06.004Search in Google Scholar PubMed

Chen, S., Liu, A.R., An, F.M., Yao, W.B., and Gao X.D. (2012a). Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer’s disease by exendin-4. Age (Dordr). 34, 1211–1224.10.1007/s11357-011-9303-8Search in Google Scholar PubMed PubMed Central

Chen, Y., Tian, Z., Liang, Z., Sun, S., Dai, C.L., Lee, M.H., LaFerla, F.M., Grundke-Iqbal, I., Iqbal, K., Liu, F., et al. (2012b). Brain gene expression of a sporadic (icv-STZ Mouse) and a familial mouse model (3xTg-AD mouse) of Alzheimer’s disease. PLoS One 7, e51432.10.1371/journal.pone.0051432Search in Google Scholar PubMed PubMed Central

Chen, Y., Liang, Z., Blanchard, J., Dai, C.L., Sun, S., Lee, M.H., Grundke-Iqbal, I., Iqbal, K., Liu, F., and Gong C.X. (2013). A non-transgenic mouse model (icv-STZ Mouse) of Alzheimer’s disease: similarities to and differences from the transgenic model (3xTg-AD Mouse). Mol. Neurobiol. 47, 711–725.10.1007/s12035-012-8375-5Search in Google Scholar PubMed PubMed Central

Couce, M.E., Burguera, B., Parisi, J.E., Jensen, M.D., and Lloyd R.V. (1997). Localization of leptin receptor in the human brain. Neuroendocrinology 66, 145–150.10.1159/000127232Search in Google Scholar PubMed

Craft, S., Baker, L.D., Montine, T.J., Minoshima, S., Watson, G.S., Claxton, A., Arbuckle, M., Callaghan, M., Tsai, E., Plymate S.R., et al. (2012). Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch. Neurol. 69, 29–38.10.1001/archneurol.2011.233Search in Google Scholar PubMed PubMed Central

Crane, P.K., Walker, R., Hubbard, R.A., Li, G., Nathan, D.M., Zheng, H., Haneuse, S., Craft, S., Montine, T.J., Kahn, S.E., et al. (2013). Glucose levels and risk of dementia. N. Engl. J. Med. 369, 540–548.10.1056/NEJMoa1215740Search in Google Scholar PubMed PubMed Central

De Felice, F.G. (2013). Alzheimer’s disease and insulin resistance: translating basic science into clinical applications. J. Clin. Invest. 123, 531–539.10.1172/JCI64595Search in Google Scholar PubMed PubMed Central

de la Monte, S.M. (2012). Brain insulin resistance and deficiency as therapeutic targets in Alzheimer’s disease. Curr. Alzheimer Res. 9, 35–66.10.2174/156720512799015037Search in Google Scholar PubMed PubMed Central

de la Monte, S.M. and Wands, J.R. (2005). Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system, relevance to Alzheimer’s disease. J. Alzheimers Dis. 7, 45–61.10.3233/JAD-2005-7106Search in Google Scholar

de Leon, M.J., Ferris, S.H., George, A.E., Christman, D.R., Fowler, J.S., Gentes, C., Reisberg, B., Gee, B., Emmerich, M., Yonekura, Y., et al. (1983). Positron emission tomographic studies of aging and Alzheimer disease. Am. J. Neuroradiol. 4, 568–571.Search in Google Scholar

Doherty, G.H., Beccano-Kelly, D., Yan, S.D., Gunn-Moore, F.J., and Harvey, J. (2013). Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid β. Neurobiol. Aging 34, 226–237.10.1016/j.neurobiolaging.2012.08.003Search in Google Scholar

Egefjord, L., Gejl, M., Moller, A., Braendgaard, H., Gottrup, H., Antropova, O., Moller, N., Poulsen, H.E., Gjedde, A., Brock, B., et al. (2012). Effects of liraglutide on neurodegeneration, blood flow and cognition in Alzheimer s disease - protocol for a controlled, randomized double-blinded trial. Dan. Med. J. 59, A4519.Search in Google Scholar

Ernst, A., Sharma, A.N., Elased, K.M., Guest, P.C., Rahmoune, H., and Bahn S. (2013). Diabetic db/db mice exhibit central nervous system and peripheral molecular alterations as seen in neurological disorders. Transl. Psychiatry 3, e263.10.1038/tp.2013.42Search in Google Scholar

Farr, S.A., Banks, W.A., and Morley, J.E. (2006). Effects of leptin on memory processing. Peptides 27, 1420–1425.10.1016/j.peptides.2005.10.006Search in Google Scholar

Freiherr, J., Hallschmid, M., Frey, W.H., 2nd, Brunner, Y.F., Chapman, C.D., Holscher, C., Craft, S., De Felice, F.G., and Benedict, C. (2013). Intranasal insulin as a treatment for Alzheimer’s disease: a review of basic research and clinical evidence. CNS Drugs 27, 505–514.10.1007/s40263-013-0076-8Search in Google Scholar

Friedland, R.P., Budinger, T.F., Ganz, E., Yano, Y., Mathis, C.A., Koss, B., Ober, B.A., Huesman, R.H., and Derenzo, S.E. (1983). Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [¹⁸F]fluorodeoxyglucose. J. Comput. Assist. Tomogr. 7, 590–598.10.1097/00004728-198308000-00003Search in Google Scholar

Friedman, J.M. and Halaas, J.L. (1998). Leptin and the regulation of body weight in mammals. Nature 395, 763–770.10.1038/27376Search in Google Scholar

Ghilardi, N. and Skoda, R.C. (1997). The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrinol. 11, 393–399.10.1210/mend.11.4.9907Search in Google Scholar

Greenwood, C.E. and Winocur, G. (1990). Learning and memory impairment in rats fed a high saturated fat diet. Behav. Neural. Biol, 53, 74–87.10.1016/0163-1047(90)90831-PSearch in Google Scholar

Hegyi, K., Fulop, K., Kovacs, K., Toth, S., and Falus, A. (2004). Leptin-induced signal transduction pathways. Cell. Biol. Int. 28, 159–169.10.1016/j.cellbi.2003.12.003Search in Google Scholar PubMed

Hiltunen, M., Khandelwal, V.K., Yaluri, N., Tiilikainen, T., Tusa, M., Koivisto, H., Krzisch, M., Vepsalainen, S., Makinen, P., Kemppainen, S., et al. (2012). Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice. J. Cell. Mol. Med. 16, 1206–1222.10.1111/j.1582-4934.2011.01384.xSearch in Google Scholar PubMed PubMed Central

Holscher, C. (2011). Diabetes as a risk factor for Alzheimer’s disease, insulin signaling impairment in the brain as an alternative model of Alzheimer’s disease. Biochem. Soc. Trans. 39, 891–897.10.1042/BST0390891Search in Google Scholar PubMed

Holscher, C. (2012). Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection. CNS Drugs 26, 871–882.10.2165/11635890-000000000-00000Search in Google Scholar PubMed

Huang, Y. and Mucke, L. (2012). Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204–1222.10.1016/j.cell.2012.02.040Search in Google Scholar PubMed PubMed Central

Julien, C., Tremblay, C., Phivilay, A., Berthiaume, L., Emond, V., Julien, P., and Calon, F. (2010). High-fat diet aggravates amyloid-β and tau pathologies in the 3xTg-AD mouse model. Neurobiol. Aging. 31, 1516–1531.10.1016/j.neurobiolaging.2008.08.022Search in Google Scholar PubMed

Kerouz, N.J., Horsch, D., Pons, S., and Kahn, C.R. (1997). Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J. Clin. Invest. 100, 3164–3172.10.1172/JCI119872Search in Google Scholar PubMed PubMed Central

Kim, K.H., Lopez-Casillas, F., Bai, D.H., Luo, X., and Pape, M.E. (1989). Role of reversible phosphorylation of acetyl-CoA carboxylase in long-chain fatty acid synthesis. FASEB. J. 3, 2250–2256.10.1096/fasebj.3.11.2570725Search in Google Scholar PubMed

Kim, B., Backus, C., Oh, S., and Feldman, E.L. (2013). Hyperglycemia-induced Tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer’s disease. J. Alzheimers Dis. 34, 727–739.10.3233/JAD-121669Search in Google Scholar PubMed PubMed Central

Knight, D.S., Mahajan, D.K., and Qiao, X. (2001). Dietary fat up-regulates the apolipoprotein E mRNA level in the Zucker lean rat brain. Neuroreport 12, 3111–3115.10.1097/00001756-200110080-00026Search in Google Scholar PubMed

Lannert, H. and Hoyer, S. (1998). Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav. Neurosci. 112, 1199–1208.10.1037/0735-7044.112.5.1199Search in Google Scholar

Leibel, R.L. (2008). Molecular physiology of weight regulation in mice and humans. Int. J. Obes. (Lond) 32 Suppl 7, S98–S108.10.1038/ijo.2008.245Search in Google Scholar

Li, X.L., Aou, S., Oomura, Y., Hori, N., Fukunaga, K., and Hori, T. (2002). Impairment of long-term potentiation and spatial memory in leptin receptor-deficient rodents. Neuroscience 113, 607–615.10.1016/S0306-4522(02)00162-8Search in Google Scholar

Li, J., Deng, J., Sheng, W., and Zuo, Z. (2012). Metformin attenuates Alzheimer’s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol. Biochem. Behav. 101, 564–574.10.1016/j.pbb.2012.03.002Search in Google Scholar PubMed PubMed Central

Lindstrom, P. (2007). The physiology of obese-hyperglycemic mice [ob/ob mice]. ScientificWorldJournal 7, 666–685.10.1100/tsw.2007.117Search in Google Scholar PubMed PubMed Central

Liu, X.J., Yuan, L., Yang, D., Han, W.N., Li, Q.S., Yang, W., Liu, Q.S., and Qi, J.S. (2013). Melatonin protects against amyloid-β-induced impairments of hippocampal LTP and spatial learning in rats. Synapse 67, 626–636.10.1002/syn.21677Search in Google Scholar PubMed

Luchsinger, J.A., Tang, M.X., Stern, Y., Shea, S., and Mayeux, R. (2001). Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in a multiethnic cohort. Am. J. Epidemiol. 154, 635–641.10.1093/aje/154.7.635Search in Google Scholar PubMed

Marwarha, G. and Ghribi, O. (2012). Leptin signaling and Alzheimer’s disease. Am J Neurodegener. Dis. 1, 245–265.Search in Google Scholar

Masek, J. and Fabry, P. (1959). High-fat diet and the development of obesity in albino rats. Experientia 15, 444–445.10.1007/BF02157708Search in Google Scholar PubMed

McClean, P.L. and Holscher, C. (2013). Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer’s disease. Neuropharmacol. 76, 57–67.10.1016/j.neuropharm.2013.08.005Search in Google Scholar PubMed

McClean, P.L., Parthsarathy, V., Faivre, E., and Holscher, C. (2011). The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer’s disease. J. Neurosci. 31, 6587–6594.10.1523/JNEUROSCI.0529-11.2011Search in Google Scholar PubMed PubMed Central

McNeilly, A.D., Williamson, R., Balfour, D.J., Stewart, C.A., and Sutherland, C. (2012). A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin. Diabetologia 55, 3061–3070.10.1007/s00125-012-2686-ySearch in Google Scholar PubMed

Mercer, J.G., Hoggard, N., Williams, L.M., Lawrence, C.B., Hannah, L.T., and Trayhurn, P. (1996). Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization. FEBS Lett. 387, 113–116.10.1016/0014-5793(96)00473-5Search in Google Scholar

Minoshima, S., Giordani, B., Berent, S., Frey, K.A., Foster, N.L., and Kuhl, D.E. (1997). Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann. Neurol. 42, 85–94.10.1002/ana.410420114Search in Google Scholar

Moloney, A.M., Griffin, R.J., Timmons, S., O’Connor, R., Ravid, R., and O’Neill, C. (2010). Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer’s disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol. Aging 31, 224–243.10.1016/j.neurobiolaging.2008.04.002Search in Google Scholar

Mosconi, L. (2005). Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease. FDG-PET studies in MCI and AD. Eur. J. Nucl. Med. Mol. Imaging 32, 486–510.10.1007/s00259-005-1762-7Search in Google Scholar

Murray-Lyon, I.M., Eddleston, A.L., Williams, R., Brown, M., Hogbin, B.M., Bennett, A., Edwards, J.C., and Taylor, K.W. (1968). Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. Lancet 2, 895–898.10.1016/S0140-6736(68)91058-1Search in Google Scholar

Oomura, Y., Hori, N., Shiraishi, T., Fukunaga, K., Takeda, H., Tsuji, M., Matsumiya, T., Ishibashi, M., Aou, S., Li, X.L., et al. (2006). Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats. Peptides 27, 2738–2749.10.1016/j.peptides.2006.07.001Search in Google Scholar PubMed

Parthsarathy, V. and Holscher, C. (2013). Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model. PloS One 8, e58784.10.1371/journal.pone.0058784Search in Google Scholar PubMed PubMed Central

Patil, S. and Chan, C. (2005). Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons. Neurosci. Lett. 384, 288–293.10.1016/j.neulet.2005.05.003Search in Google Scholar PubMed

Pedrini, S., Thomas, C., Brautigam, H., Schmeidler, J., Ho, L., Fraser, P., Westaway, D., Hyslop, P.S., Martins, R.N., Buxbaum, J.D., et al. (2009). Dietary composition modulates brain mass and solubilizable Aβ levels in a mouse model of aggressive Alzheimer’s amyloid pathology. Mol. Neurodegener. 4, 40–49.10.1186/1750-1326-4-40Search in Google Scholar PubMed PubMed Central

Porter, W.D., Flatt, P.R., Holscher, C., and Gault, V.A. (2013). Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice. Int. J. Obes. (Lond). 37, 678–684.10.1038/ijo.2012.91Search in Google Scholar PubMed

Pouryamout, L., Dams, J., Wasem, J., Dodel, R., and Neumann, A. (2012). Economic evaluation of treatment options in patients with Alzheimer’s disease: a systematic review of cost-effectiveness analyses. Drugs 72, 789–802.10.2165/11631830-000000000-00000Search in Google Scholar PubMed

Reger, M.A., Watson, G.S., Frey, W.H., 2nd, Baker, L.D., Cholerton, B., Keeling, M.L., Belongia, D.A., Fishel, M.A., Plymate, S.R., Schellenberg, G.D., et al. (2006). Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol. Aging 27, 451–458.10.1016/j.neurobiolaging.2005.03.016Search in Google Scholar PubMed

Reger, M.A., Watson, G.S., Green, P.S., Baker, L.D., Cholerton, B., Fishel, M.A., Plymate, S.R., Cherrier, M.M., Schellenberg, G.D., Frey, W.H., 2nd, et al. (2008). Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-β in memory-impaired older adults. J. Alzheimers Dis. 13, 323–331.10.3233/JAD-2008-13309Search in Google Scholar PubMed PubMed Central

Salkovic-Petrisic, M. and Hoyer, S. (2007). Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J. Neural. Transm. Suppl. 72, 217–233.10.1007/978-3-211-73574-9_28Search in Google Scholar PubMed

Salkovic-Petrisic, M., Knezovic, A., Hoyer, S., and Riederer, P. (2013). What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research. J. Neural. Transm. 120, 233–252.10.1007/s00702-012-0877-9Search in Google Scholar PubMed

Saxena, G., Patro, I.K., and Nath, C. (2011). ICV STZ induced impairment in memory and neuronal mitochondrial function: a protective role of nicotinic receptor. Behav. Brain. Res. 224, 50–57.10.1016/j.bbr.2011.04.039Search in Google Scholar PubMed

Schioth, H.B., Craft, S., Brooks, S.J., Frey, W.H., 2nd, and Benedict, C. (2012). Brain insulin signaling and Alzheimer’s disease: current evidence and future directions. Mol Neurobiol. 46, 4–10.10.1007/s12035-011-8229-6Search in Google Scholar PubMed PubMed Central

Schnedl, W.J., Ferber, S., Johnson, J.H., and Newgard, C.B. (1994). STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43, 1326–1333.10.2337/diab.43.11.1326Search in Google Scholar PubMed

Schraml, F., Chen, K., Ayutyanont, N., Auttawut, R., Langbaum, J.B., Lee, W., Liu, X., Bandy, D., Reeder, S.Q., Alexander, G.E., et al. (2013). Association between an Alzheimer’s Disease-Related Index and Gene Dose. PLoS One 8, e67163.10.1371/journal.pone.0067163Search in Google Scholar PubMed PubMed Central

Schrijvers, E.M., Witteman, J.C., Sijbrands, E.J., Hofman, A., Koudstaal, P.J., and Breteler, M.M. (2010). Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study. Neurology 75, 1982–1987.10.1212/WNL.0b013e3181ffe4f6Search in Google Scholar PubMed PubMed Central

Selkoe, D.J. (2000). Toward a comprehensive theory for Alzheimer’s disease. Hypothesis, Alzheimer’s disease is caused by the cerebral accumulation and cytotoxicity of amyloid β-protein. Ann. N.Y. Acad. Sci. 924, 17–25.10.1111/j.1749-6632.2000.tb05554.xSearch in Google Scholar PubMed

Serbedzija, P. and Ishii, D.N. (2012). Insulin and insulin-like growth factor prevent brain atrophy and cognitive impairment in diabetic rats. Indian. J. Endocrinol. Metab. 16, S601–S610.Search in Google Scholar

Shingo, A.S., Kanabayashi, T., Murase T., and Kito, S. (2012). Cognitive decline in STZ-3V rats is largely due to dysfunctional insulin signaling through the dentate gyrus. Behav. Brain. Res. 229, 378–383.10.1016/j.bbr.2012.01.034Search in Google Scholar PubMed

Shingo, A.S., Kanabayashi, T., Kito, S., and Murase, T. (2013). Intracerebroventricular administration of an insulin analogue recovers STZ-induced cognitive decline in rats. Behav. Brain. Res. 241, 105–111.10.1016/j.bbr.2012.12.005Search in Google Scholar PubMed

Shonesy, B.C., Thiruchelvam, K., Parameshwaran, K., Rahman, E.A., Karuppagounder, S.S., Huggins, K.W., Pinkert, C.A., Amin, R., Dhanasekaran, M., Suppiramaniam, V. (2012). Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents. Neurobiol. Aging. 33, 430.e5–e18.10.1016/j.neurobiolaging.2010.12.002Search in Google Scholar PubMed

Singh, S., Kushwah, A.S., Singh, R., Farswan, M., and Kaur, R. (2012). Current therapeutic strategy in Alzheimer’s disease. Eur. Rev. Med. Pharmacol. Sci. 16, 1651–1664.Search in Google Scholar

Steen, E., Terry, B.M., Rivera, E.J., Cannon, J.L., Neely, T.R., Tavares, R., Xu, X.J., Wands, J.R., and de la Monte, S.M. (2005). Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease – is this type 3 diabetes? J. Alzheimers. Dis. 7, 63–80.10.3233/JAD-2005-7107Search in Google Scholar

Strachan, M.W. (2005). Insulin and cognitive function in humans, experimental data and therapeutic considerations. Biochem. Soc. Trans. 33, 1037–1040.10.1042/BST0331037Search in Google Scholar

Szkudelski, T. (2001). The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol. Res. 50, 537–546.Search in Google Scholar

Takeda, S., Sato, N., Uchio-Yamada, K., Sawada, K., Kunieda, T., Takeuchi, D., Kurinami, H., Shinohara, M., Rakugi, H., and Morishita, R. (2010). Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes. Proc. Natl. Acad. Sci. USA 107, 7036–7041.10.1073/pnas.1000645107Search in Google Scholar PubMed PubMed Central

Talbot, K., Wang, H.Y., Kazi, H., Han, L.Y., Bakshi, K.P., Stucky, A., Fuino, R.L., Kawaguchi, K.R., Samoyedny, A.J., Wilson, R.S., et al. (2012) Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316–1338.10.1172/JCI59903Search in Google Scholar PubMed PubMed Central

van den Brink, G.R., O’Toole, T., Hardwick, J.C., van den Boogaardt, D.E., Versteeg, H.H., van Deventer, S.J., and Peppelenbosch, M.P. (2000). Leptin signaling in human peripheral blood mononuclear cells, activation of p38 and p42/44 mitogen-activated protein (MAP) kinase and p70 S6 kinase. Mol. Cell. Biol. Res. Commun. 4, 144–150.10.1006/mcbr.2001.0270Search in Google Scholar PubMed

Vignini, A., Giulietti, A., Nanetti, L., Raffaelli, F., Giusti, L., Mazzanti, L., and Provinciali, L. (2013). Alzheimer’s disease and diabetes: new insights and unifying therapies. Curr. Diabetes. Rev. 9, 218–227.10.2174/1573399811309030003Search in Google Scholar PubMed

Wang, Z. and Gleichmann, H. (1998). GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 47, 50–56.10.2337/diab.47.1.50Search in Google Scholar PubMed

Wang, X., Zheng, W., Xie, J.W., Wang, T., Wang, S.L., Teng, W.P., and Wang, Z.Y. (2010). Insulin deficiency exacerbates cerebral amyloidosis and behavioral deficits in an Alzheimer transgenic mouse model. Mol. Neurodegener. 5, 46–54.10.1186/1750-1326-5-46Search in Google Scholar PubMed PubMed Central

Winzell, M.S. and Ahren, B. (2004). The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53 Suppl 3, S215–S219.Search in Google Scholar

Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., and Friedman, J.M. (1994). Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425–432.10.1038/372425a0Search in Google Scholar PubMed